• 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • 2021-03
  • br Conclusion br In summary this study demonstrates that


    In summary, this Dorsomorphin study demonstrates that patients with thy-roid cancer have a clear need for a strong patient-surgeon relationship, characterized by informational and emotional support as well as respect for the individual. When these needs were met, patients experienced a deep-seated sense of reassurance, whereas unmet needs increased worry and anxiety. Studies show that meeting patients’ needs improves communication and outcomes, including health-related quality of life. Because quality of life is an outcome known to be worse in patients with thyroid cancer compared to those with other more aggressive malignancies, further work in this area is necessary. In the early 1900s, William Osler taught, “Care more for the individual patient than for the special features of the disease.Put yourself in his [or her] place.The kindly word, the cheerful greeting, the sympathetic lookdthese the patient understands.” Nearly 100 y later, a gap  remains in providing patients with adequate support. This study highlights areas where we can improve the preoperative experience for patients with thyroid cancer, and likely other malignant diseases. We anticipate that increasing surgeons’ repertoire of skills in developing a robust patient-surgeon relationship will be critical to improving patient outcomes.
    These data were presented at the 102nd Annual American College of Surgeons Meeting in Washington, DC, on October 20, 2016.
    This work was supported by the University of Wisconsin Carbone Cancer Center Support Grant P30 CA014520 and the National Cancer Institute of the National Institutes of Health (NIH) award number R01 CA176911 and K08 CA230204. The content is solely the responsibility of the authors and does not necessarily represent Dorsomorphin the official views of the NIH. In addition, the NIH did not play a role in the design or conduct of the study; data collection, management, analysis, or interpreta-tion; manuscript preparation, review, or approval; and deci-sion to submit the manuscript for publication. The principal investigator/senior author had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
    Authors’ contributions: The study concept and design was performed by Dr Pitt, Dr Orne, Dr Macdonald, Dr Connor, and Dr Sippel. Data analysis and interpretation were performed by all authors. The manuscript was drafted by Dr Pitt, Ms. Wendt, and Ms. Saucke, and critically revised by all authors. Dr Sippel and Dr Connor obtained funding for the study.
    The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in special senses article.
    1. Davies L, Morris LG, Haymart M, et al. American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: the increasing incidence of thyroid cancer. Endocr Pract. 2015;21:686e696.
    4. A Snap Shot of Thyroid Cancer: Incidence and Mortality. National Cancer Institute. [Webpage]. http://www.cancer. gov/research/progress/snapshots/thyroid. Accessed June 11, 2018.
    5. American Cancer Society. Cancer facts & Figures 2017. Atlanta: American Cancer Society; 2017.
    7. Adam MA, Pura J, Gu L, et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of
    10. Husson O, Haak HR, Buffart LM, et al. Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncol. 2013;52:249e258.
    11. Husson O, Nieuwlaat WA, Oranje WA, Haak HR, van de Poll-Franse LV, Mols F. Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry. Thyroid. 2013;23:1247e1255.